2020 NICE guideline update: Good news for pregnant women with type 1 diabetes and past or current gestational diabetes

Research output: Contribution to journalComment/debatepeer-review

8 Citations (Scopus)
29 Downloads (Pure)


In December 2020, the National Institute for Health and Care Excellence (NICE) reviewed the evidence and updated their recommendations on intermittently scanned (commonly known as Flash) and Continuous Glucose Monitoring (CGM) during pregnancy for women with type 1 diabetes (1). The NICE guidelines now recommend offering CGM to all pregnant women with type 1 diabetes to help them meet their pregnancy glucose targets and improve neonatal outcomes. Their evidence review, based on the CONCEPTT randomised trial (2) and a Swedish observational study (3) found that, compared to capillary glucose monitoring, CGM resulted in more women achieving their blood glucose targets, fewer caesarean sections and fewer neonatal intensive care admissions.
Original languageEnglish
Article numbere14576
JournalDiabetic Medicine
Issue number6
Early online date1 Apr 2021
Publication statusPublished - Jun 2021

Cite this